These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 574019)
21. Relationship between protein binding and extravascular drug concentrations of a water-soluble drug, cytosine arabinoside. Slevin ML; Johnston A; Woollard RC; Piall EM; Lister TA; Turner P J R Soc Med; 1983 May; 76(5):365-8. PubMed ID: 6575177 [TBL] [Abstract][Full Text] [Related]
22. High-performance liquid chromatographic assay for cytosine arabinoside and uracil arabinoside in cerebrospinal fluid and plasma. Riccardi A; Servidei T; Lasorella A; Riccardi R J Chromatogr; 1989 Dec; 497():302-7. PubMed ID: 2625467 [No Abstract] [Full Text] [Related]
23. Development and application of a radioimmunoassay for methotrexate. Aherne GW; Piall EM; Marks V Br J Cancer; 1977 Nov; 36(5):608-17. PubMed ID: 588422 [TBL] [Abstract][Full Text] [Related]
24. Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration. Groothuis DR; Benalcazar H; Allen CV; Wise RM; Dills C; Dobrescu C; Rothholtz V; Levy RM Brain Res; 2000 Feb; 856(1-2):281-90. PubMed ID: 10677637 [TBL] [Abstract][Full Text] [Related]
25. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine. Someya H; Waud WR; Parker WB Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016 [TBL] [Abstract][Full Text] [Related]
26. Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusion. Slevin ML; Piall EM; Aherne GW; Johnston A; Lister TA Cancer Chemother Pharmacol; 1983; 10(2):112-4. PubMed ID: 6572569 [TBL] [Abstract][Full Text] [Related]
27. Determination of cytarabine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatography. Breithaupt H; Schick J J Chromatogr; 1981 Sep; 225(1):99-106. PubMed ID: 7298764 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection. Uchiyama M; Takamatsu Y; Ogata K; Matsumoto T; Jimi S; Tamura K; Hara S Biomed Chromatogr; 2013 Jul; 27(7):818-20. PubMed ID: 23420764 [TBL] [Abstract][Full Text] [Related]
29. Determination of 3H-labelled cytosine arabinoside and eight metabolites in cell extracts by high-performance liquid chromatography and scintillation spectrometry. Wang LM; Woodward CN; White JC; Capizzi RL J Chromatogr; 1989 Jul; 491(2):331-40. PubMed ID: 2808619 [TBL] [Abstract][Full Text] [Related]
30. Cytosine arabinoside transport by human leukaemic cells. Wiley JS; Jones SP; Sawyer WH Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1067-74. PubMed ID: 6684553 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous determination of 6-azacytidine, 6-azauridine, arabinoside cytosine and arabinoside uracil in blood by liquid chromatography. Galushko SV; Shishkina IP J Pharm Biomed Anal; 1992; 10(10-12):1093-5. PubMed ID: 1284337 [No Abstract] [Full Text] [Related]
33. Determination of phencyclidine by radioimmunoassay. Heveran JE; Anthony M; Ward C J Forensic Sci; 1980 Jan; 25(1):79-87. PubMed ID: 7391786 [TBL] [Abstract][Full Text] [Related]
34. Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells. Jamieson GP; Snook MB; Bradley TR; Bertoncello I; Wiley JS Cancer Res; 1989 Jan; 49(2):309-13. PubMed ID: 2910450 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics. Liang D; Wang W; Jiang X; Yin S J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():14-19. PubMed ID: 24880220 [TBL] [Abstract][Full Text] [Related]
36. A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3). Chopra IJ J Clin Invest; 1974 Sep; 54(3):583-92. PubMed ID: 4211761 [TBL] [Abstract][Full Text] [Related]
37. The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitro. Gao XZ; Yin MY; Preisler HD Anticancer Res; 1989; 9(4):1053-5. PubMed ID: 2683990 [TBL] [Abstract][Full Text] [Related]
38. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Gargosky SE; Pham HM; Wilson KF; Liu F; Giudice LC; Rosenfeld RG Endocrinology; 1992 Dec; 131(6):3051-60. PubMed ID: 1280211 [TBL] [Abstract][Full Text] [Related]
39. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells. Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470 [TBL] [Abstract][Full Text] [Related]
40. Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Damon LE; Plunkett W; Linker CA Cancer Res; 1991 Aug; 51(16):4141-5. PubMed ID: 1868435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]